Jan Steyaert

Jan Steyaert, ir., Ph.D., is professor at the Vrije Universiteit Brussel. He is currently director of the Structural Biology Brussels lab (Vrije Universiteit Brussel) and Deputy-Director of the Structural Biology Research Center of VIB. Jan has been instrumental in the foundation of Ablynx and AgroSavfe, two VIB-VUB biotech spin-offs that valorize a unique family of camelid single domain antibodies.

Jan pioneered the use of CONFO® bodies (sdAbs) in structural biology. The elucidation of the first GPCR structures in the agonist-bound active state, solved in collaboration with the Kobilka lab (Stanford University), demonstrated the power of CONFO® bodies to lock drug targets in inherent instable functional states. Recent work focussed on exploiting the conformational complexity of therapeutic targets for CONFO® body enabled drug discovery.

Jan Steyaert is the Founder and Senior Advisor at Confo Therapeutics, based in Europe. With a background in Biotechnology, Jan Steyaert has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.